SCHEMBL16299527

SCHEMBL16299527

CN(C)CCCN1CCN(C(=O)c2ccc(I)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 7/20 0.51
HTR2A P28223 3/20 0.48
SIGMAR1 Q99720 1/20 0.48
LSS P48449 1/20 0.47
ALDH1A1 P00352 2/20 0.47
POLB P06746 1/20 0.47
DRD3 P35462 1/20 0.46
KDM4E B2RXH2 1/20 0.46
MAPT P10636 1/20 0.46
CNR2 P34972 1/20 0.46
L3MBTL3 Q96JM7 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
KCNH2 Q12809 1/20 0.45
HRH3 Q9Y5N1 2/20 0.44
MGLL Q99685 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10086564 0.88 KCNA5 (0.56) DRD2HTR2ASIGMAR1LSSALDH1A1
SCHEMBL16314493 0.86 DRD2 (0.51) DRD2HTR2ASIGMAR1LSSALDH1A1
SCHEMBL16299414 0.80 ALDH1A1 (0.65) DRD2HTR2ASIGMAR1ALDH1A1POLB
SCHEMBL13211936 0.79 KCNA5 (0.59) DRD2LSSALDH1A1POLBDRD3
SCHEMBL2965532 0.78 ALDH1A1 (0.56) LSSALDH1A1POLBMAPTMEN1
SCHEMBL16358258 0.78 DRD3 (0.61) DRD2DRD3MEN1KMT2A
SCHEMBL6339805 0.78 ALDH1A1 (0.52) DRD2LSSALDH1A1POLBDRD3
SCHEMBL17888404 0.77 DRD3 (0.59) DRD2LSSALDH1A1POLBDRD3
SCHEMBL2235076 0.76 POLB (0.69) ALDH1A1POLBL3MBTL3MEN1KMT2A
SCHEMBL17886732 0.76 HPGD (0.65) ALDH1A1POLBKDM4EMAPTCNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1871375-B1 CARBOLINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER PTC THERAPEUTICS INC (US) 2012-02-29 EP disclosed
WO-2008127714-A1 ADMINISTRATION OF CARBOLINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISEASES PTC THERAPEUTICS, INC. (US) 2008-10-23 WO disclosed